Combination Treatment for Augmenting Language in Children With ASD

Summary

The study will consist of two main elements: the enrollment of 72 children aged 6-11 years with ASD and low language competency to receive a thrice-weekly one hour language intervention for 12 weeks; and, beginning at the same time, subjects will be equally randomized to receive either aripiprazole (Abilify) (flexibly dosed from 2-10 mg per day) or placebo for 12 weeks.

Timeline

Start

2012-06

Primary completion

2019-12

Completion

2019-12

Drugs

Indications